Gen House

Suzhou, China · Founded 2014 · In IPO Registration

Developer of original anti-tumor drugs designed for anti-cancer therapeutics. Gen House is based in Suzhou, China and was founded in 2014. Its last reported valuation was $268 million in Jan 2026. It has raised $121 million.

Last reported valuation
$268.3M
Oct 2026
Priced at
—
Total raised
$120.5M
Last round
—

Who backs Gen House?

23 investors
InvestorType
Shenzhen Capital GroupVenture capital
Green Pine Capital PartnersVenture capital
Legend StarVenture capital
YuanBio Venture CapitalVenture capital
DPH CapitalHedge fund
In CapitalOther
BOHE Angel Fund—
Gandao Investment Holding Company—
Genova—
Guangzhou Industrial Investment Holding Group—
+ 13 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Gen House investors

23 investors are on record for Gen House, including Shenzhen Capital Group, Green Pine Capital Partners, Legend Star and YuanBio Venture Capital. By type, the record holds 4 venture capital firms and 1 hedge fund.

Free account
More of Gen House with a free account
  • ·The complete investor list: 23 names
  • ·Watch Gen House: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 23 firms already write checks for companies like Gen House. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View